Search Results for: HCV

February 4, 2016February 4, 2016

Zepatier, a New Chronic Hepatitis C Treatment, Receives FDA Approval

News

The U.S. Food and Drug Administration (FDA) has approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of adult patients with chronic hepatitis C virus (HCV) genotypes ... Read more

February 2, 2016May 20, 2016

AbbVie’s Six Hepatitis C Clinical Trials Now Enrolling Patients

News

AbbVie has announced it will initiate six global Phase 3 clinical studies to evaluate the safety and efficacy of two drug candidates: ABT-530, an NS5A inhibitor, and ABT-493, an NS3/4A protease inhibitor, ... Read more

January 26, 2016May 20, 2016

Institute Awards $29.5 Million in Grants to Study Hepatitis C Virus

News

Two grants totaling $29.5 million to fund two patient-centered comparative research studies on clinical effectiveness focusing on the hepatitis C (HCV) virus infection have been approved by the Patient-Centered Outcomes Research ... Read more

January 5, 2016May 20, 2016

Inmates with Hepatitis C Seen as Rare Chance to Test Prevention Efforts

News

More than 1 in every 9 Hepatitis C (HCV) patients in Canada spend time in a correctional institution every year, giving researchers a unique opportunity to focus HCV prevention and control efforts in ... Read more

December 8, 2015December 8, 2015

Hepatitis C Patients on Medicaid Often Denied Coverage for New Effective Drugs

News

According to a new study, 46% of Medicaid patients with the chronic hepatitis C virus (HCV) who were prescribed new and highly effective antiviral drugs were denied insurance coverage because the treatments were not considered ... Read more

December 2, 2015December 2, 2015

Medicines Patent Pool Partners With Bristol-Myers Squibb To Bring Hepatitis C Drug To Less Developed Countries

News

The Medicines Patent Pool (MPP) has announced its first license agreement for a hepatitis C medicine, signed with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral that has been proved ... Read more

November 19, 2015November 19, 2015

AbbVie’s Chronic Hepatitis C Treatments Working Well in Trials

News

AbbVie recently announced encouraging results from the SURVEYOR clinical trials of its investigational HCV drug regimen, ABT-493 and ABT-530, in non-cirrhotic patients who are positive for chronic hepatitis C virus (HCV) infection. Specifically, ABT-493, an inhibitor of the NS3/4A protease, ... Read more

November 17, 2015November 17, 2015

Risk of Developing Hepatocellular Carcinoma After Hepatitis C Virus Treatment Assessed in New Study

News

The risk of developing hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV) who achieved sustained virologic response (SVR) after completion of antiviral therapy has been assessed in a recent ... Read more

October 29, 2015October 29, 2015

Hepatitis C Linked With Marijuana Use in Study

News

Results from a recent study presented during the 2015 Annual Meeting of the American College of Gastroenterology showed that the use of marijuana is associated with a positive hepatitis C antibody serum ... Read more

October 13, 2015October 13, 2015

iPhone App Captures Real-world Daily Impacts Of Coping With Hepatitis C To Help Drive Improved Treatment

News

A new app for Apple iPhones created by researchers at Boston Children’s Hospital, is designed to enable hepatitis C patients to participate in outcomes research from their iPhone. C Tracker, ... Read more